Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Tuberculosis

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 213 articles:
HTML format



Single Articles


    June 2022
  1. HEYSELL SK, Mpagama SG, Ogarkov OB, Conaway M, et al
    Pharmacokinetic-pharmacodynamic determinants of clinical outcomes for rifampin-resistant tuberculosis: a multi-site prospective cohort study.
    Clin Infect Dis. 2022 Jun 22. pii: 6613372. doi: 10.1093.
    PubMed     Abstract available


  2. MATHAD JS, Queiroz ATL, Bhosale R, Alexander M, et al
    Transcriptional analysis for tuberculosis in pregnant women from the PRACHITi study.
    Clin Infect Dis. 2022 Jun 10. pii: 6605083. doi: 10.1093.
    PubMed     Abstract available


  3. HORSBURGH CR, Jo Y, Nichols B, Jenkins HE, et al
    The contribution of reinfection to annual rate of tuberculosis infection (ARI) and incidence of TB disease.
    Clin Infect Dis. 2022 Jun 6. pii: 6603293. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  4. CHOI H, Han K, Jung JH, Park SH, et al
    Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study.
    Clin Infect Dis. 2022 May 25. pii: 6591843. doi: 10.1093.
    PubMed     Abstract available


  5. COX H, Workman L, Bateman L, Franckling-Smith Z, et al
    Oral swabs tested with Xpert MTB/RIF Ultra for diagnosis of pulmonary tuberculosis in children: a diagnostic accuracy study.
    Clin Infect Dis. 2022 May 17. pii: 6586837. doi: 10.1093.
    PubMed     Abstract available


  6. LE V, Pascopella L, Westenhouse J, Barry P, et al
    A cross-sectional study of patients with extrapulmonary tuberculosis and normal chest radiographs - what characteristics were associated with sputum culture positivity?
    Clin Infect Dis. 2022 May 6. pii: 6581570. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  7. PODELL BK, Aibana O, Huang CC, DiLisio JE, et al
    The Impact of Vitamin A Deficiency on Tuberculosis Progression.
    Clin Infect Dis. 2022 Apr 29. pii: 6576158. doi: 10.1093.
    PubMed     Abstract available


  8. GOVENDER I, Karat AS, Olivier S, Baisley K, et al
    Correction to: Prevalence of Mycobacterium tuberculosis in Sputum and Reported Symptoms Among Clinic Attendees Compared With a Community Survey in Rural South Africa.
    Clin Infect Dis. 2022 Apr 27. pii: 6574994. doi: 10.1093.
    PubMed    


  9. CAMPBELL JR, Chan ED, Falzon D, Trajman A, et al
    Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis.
    Clin Infect Dis. 2022 Apr 27. pii: 6574751. doi: 10.1093.
    PubMed     Abstract available


  10. HUGHES JA, Solans BP, Draper HR, Schaaf HS, et al
    Pharmacokinetics and Safety of Bedaquiline in HIV-Positive and Negative Older Children and Adolescents with Rifampicin-Resistant Tuberculosis.
    Clin Infect Dis. 2022 Apr 4. pii: 6563170. doi: 10.1093.
    PubMed     Abstract available


  11. HOLZMAN SB, Perry A, Saleeb P, Pyan A, et al
    Evaluation of the latent tuberculosis care cascade among public health clinics in the United States.
    Clin Infect Dis. 2022 Apr 1. pii: 6562172. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  12. NATHELLA PK, Moideen K, Viswanathan V, Sivakumar S, et al
    Heightened microbial translocation is a prognostic biomarker of recurrent tuberculosis.
    Clin Infect Dis. 2022 Mar 30. pii: 6555776. doi: 10.1093.
    PubMed     Abstract available


  13. BATEMAN M, Wolf A, Chimukangara B, Brust JCM, et al
    Adherence measured using electronic dose monitoring is associated with emergent antiretroviral resistance and poor outcomes in patients co-infected with HIV/AIDS and multidrug-resistant tuberculosis.
    Clin Infect Dis. 2022 Mar 30. pii: 6555759. doi: 10.1093.
    PubMed     Abstract available


  14. NATHAVITHARANA RR, Mishra H, Sullivan A, Hurwitz S, et al
    Predicting airborne infection risk: Association between personal ambient carbon dioxide level monitoring and incidence of tuberculosis infection in South African health workers.
    Clin Infect Dis. 2022 Mar 26. pii: 6554598. doi: 10.1093.
    PubMed     Abstract available


  15. MCCALLUM AD, Pertinez HE, Chirambo AP, Sheha I, et al
    High intrapulmonary rifampicin and isoniazid concentrations are associated with rapid sputum bacillary clearance in patients with pulmonary tuberculosis.
    Clin Infect Dis. 2022 Mar 23. pii: 6553299. doi: 10.1093.
    PubMed     Abstract available


  16. NAIDOO K, Moodley MC, Hassan-Moosa R, Dookie N, et al
    Recurrent subclinical tuberculosis among ART accessing participants: Incidence, clinical course, and outcomes.
    Clin Infect Dis. 2022 Mar 5. pii: 6542969. doi: 10.1093.
    PubMed     Abstract available


  17. HUERGA H, Khan U, Bastard M, Mitnick CD, et al
    Safety and effectiveness outcomes from a 14-country cohort of patients with multi-drug resistant tuberculosis treated concomitantly with bedaquiline, delamanid and other second-line drugs.
    Clin Infect Dis. 2022 Mar 4. pii: 6542212. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  18. SHRESTHA S, Winglee K, Hill A, Shaw T, et al
    Model-based analysis of tuberculosis genotype clusters in the United States reveals high degree of heterogeneity in transmission, and state-level differences across California, Florida, New York, and Texas.
    Clin Infect Dis. 2022 Feb 10. pii: 6526443. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  19. PALMER M, Gunasekera KS, van der Zalm MM, Morrison J, et al
    The diagnostic accuracy of chest radiographic features for pediatric intrathoracic tuberculosis.
    Clin Infect Dis. 2022 Jan 7. pii: 6500009. doi: 10.1093.
    PubMed     Abstract available


  20. MAVE V, Chen L, Ranganathan UD, Kadam D, et al
    Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India.
    Clin Infect Dis. 2022 Jan 4. pii: 6497515. doi: 10.1093/cid/ciab1067.
    PubMed     Abstract available


  21. STUCK L, van Haaster AC, Kapata-Chanda P, Klinkenberg E, et al
    How 'subclinical' is subclinical tuberculosis? An analysis of national prevalence survey data from Zambia.
    Clin Infect Dis. 2022 Jan 4. pii: 6497425. doi: 10.1093/cid/ciab1050.
    PubMed     Abstract available


    December 2021
  22. LI H, Chee CBE, Geng T, Pan A, et al
    Joint associations of multiple lifestyle factors with risk of active tuberculosis in the population: the Singapore Chinese Health Study.
    Clin Infect Dis. 2021 Dec 27. pii: 6484917. doi: 10.1093.
    PubMed     Abstract available


  23. MARTINSON NA, Lebina L, Webb EL, Ratsela A, et al
    Household contact tracing with intensified tuberculosis and HIV screening in South Africa: a cluster randomised trial.
    Clin Infect Dis. 2021 Dec 24. pii: 6482200. doi: 10.1093/cid/ciab1047.
    PubMed     Abstract available


  24. KHALIFE S, Jenkins HE, Dolynska M, Terleieva I, et al
    Incidence and Mortality of Extrapulmonary Tuberculosis in Ukraine: Analysis of National Surveillance Data.
    Clin Infect Dis. 2021 Dec 20. pii: 6470933. doi: 10.1093/cid/ciab1018.
    PubMed     Abstract available


  25. SINHA P, Lakshminarayanan SL, Cintron C, Narasimhan PB, et al
    Nutritional Supplementation Would Be Cost-Effective for Reducing Tuberculosis Incidence and Mortality in India: The Ration Optimization to Impede Tuberculosis (ROTI-TB) model.
    Clin Infect Dis. 2021 Dec 15. pii: 6462896. doi: 10.1093/cid/ciab1033.
    PubMed     Abstract available


  26. HAMILTON CD
    Who Knew? Injectable TB Drugs Are Not Equal, Despite Drug Susceptibility Testing.
    Clin Infect Dis. 2021;73:e3937-e3938.
    PubMed    


  27. MOED S, Suprenant M, Odjidja EN, Meguid T, et al
    Economic Evaluation of Screening Interventions for Drug-induced Liver Injury.
    Clin Infect Dis. 2021;73:e3959-e3965.
    PubMed     Abstract available


  28. GOVENDER I, Karat AS, Olivier S, Baisley K, et al
    Prevalence of Mycobacterium tuberculosis in sputum and reported symptoms among clinic attendees compared to a community survey in rural South Africa.
    Clin Infect Dis. 2021 Dec 3. pii: 6433207. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  29. KEMPKER RR, Smith AGC, Avaliani T, Gujabidze M, et al
    Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness.
    Clin Infect Dis. 2021 Nov 29. pii: 6446239. doi: 10.1093.
    PubMed     Abstract available


  30. THEE S, Basu Roy R, Blazquez-Gamero D, Falcon-Neyra L, et al
    Treatment and outcome in children with tuberculous meningitis - a multi-centre Paediatric Tuberculosis Network European Trials Group study.
    Clin Infect Dis. 2021 Nov 27. pii: 6444805. doi: 10.1093.
    PubMed     Abstract available


  31. PADMAPRIYDARSINI C, Mamulwar M, Mohan A, Shanmugam P, et al
    Randomized trial of Metformin with Anti-tuberculosis drugs For Early Sputum Conversion in Adults with Pulmonary Tuberculosis.
    Clin Infect Dis. 2021 Nov 26. pii: 6444297. doi: 10.1093.
    PubMed     Abstract available


  32. VELEN K, Nhung NV, Anh NT, Cuong PD, et al
    Risk Factors for Tuberculosis (TB) Among Household Contacts of Patients With Smear-Positive TB in 8 Provinces of Vietnam: A Nested Case-Control Study.
    Clin Infect Dis. 2021;73:e3358-e3364.
    PubMed     Abstract available


  33. DAS M, Dalal A, Laxmeshwar C, Ravi S, et al
    One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India.
    Clin Infect Dis. 2021;73:e3496-e3504.
    PubMed     Abstract available


  34. HALEY C, Rowlinson MC, Ashkin D
    Tuberculosis Therapy: "In Pursuit of Perfection".
    Clin Infect Dis. 2021;73:e3529-e3530.
    PubMed    


    October 2021
  35. DOS SANTOS PCP, da Silva Santos A, de Oliveira RD, da Silva BO, et al
    Pooling Sputum Samples for Efficient Mass Tuberculosis Screening in Prisons.
    Clin Infect Dis. 2021 Oct 28. pii: 6413467. doi: 10.1093.
    PubMed     Abstract available


  36. KUMAR GS, Pezzi C, Payton C, Mamo B, et al
    Health of Asylees Compared to Refugees in the United States Using Domestic Medical Examination Data, 2014-2016: A Cross-Sectional Analysis.
    Clin Infect Dis. 2021;73:1492-1499.
    PubMed     Abstract available


  37. DENTI P, Wasmann RE, van Rie A, Winckler J, et al
    Optimizing dosing and fixed-dose combinations of rifampicin, isoniazid, and pyrazinamide in pediatric patients with tuberculosis: a prospective population pharmacokinetic study.
    Clin Infect Dis. 2021 Oct 19. pii: 6403131. doi: 10.1093.
    PubMed     Abstract available


  38. HUANG W, Chiu NC, Chi H, Huang FY, et al
    Inoculation Age of Bacillus Calmette-Guerin Tokyo-172 Strain and Vaccine-related Adverse Reactions in Taiwan Birth Cohort of 2012-2017.
    Clin Infect Dis. 2021;73:e1554-e1559.
    PubMed     Abstract available


  39. MACLEAN E, Dendukuri N
    Latent Class Analysis and the Need for Clear Reporting of Methods.
    Clin Infect Dis. 2021;73:e2285-e2286.
    PubMed    


  40. IMPERIAL MZ, Nedelman JR, Conradie F, Savic RM, et al
    Proposed linezolid dosing strategies to minimize adverse events for treatment of extensively drug-resistant tuberculosis.
    Clin Infect Dis. 2021 Oct 4. pii: 6380680. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  41. OLOMI W, Biraro IA, Kilonzo K, Te Brake L, et al
    Tuberculosis preventive therapy for people with diabetes mellitus.
    Clin Infect Dis. 2021 Sep 10. pii: 6368159. doi: 10.1093.
    PubMed    


  42. ACHARYA MP, Pradeep SP, Murthy VS, Chikkannaiah P, et al
    CD38+CD27-TNF-alpha + on Mtb-specific CD4+ T Cells Is a Robust Biomarker for Tuberculosis Diagnosis.
    Clin Infect Dis. 2021;73:793-801.
    PubMed     Abstract available


    August 2021
  43. MARTINEZ L, Ncayiyana JR, Goddard L, Botha M, et al
    Vitamin D concentrations in infancy and the risk of tuberculosis in childhood: A prospective birth cohort in Cape Town, South Africa.
    Clin Infect Dis. 2021 Aug 26. pii: 6358095. doi: 10.1093.
    PubMed     Abstract available


  44. NWONGBOUWOH MUEFONG C, Owolabi O, Donkor S, Charalambous S, et al
    Neutrophils contribute to severity of tuberculosis pathology and recovery from lung damage pre- and post-treatment.
    Clin Infect Dis. 2021 Aug 24. pii: 6356988. doi: 10.1093.
    PubMed     Abstract available


  45. CHABALA C, Turkova A, Hesseling AC, Zimba KM, et al
    Pharmacokinetics of first-line drugs in children with tuberculosis using WHO-recommended weight band doses and formulations.
    Clin Infect Dis. 2021 Aug 22. pii: 6356214. doi: 10.1093.
    PubMed     Abstract available


  46. FRITSCHI N, Wind A, Hammer J, Ritz N, et al
    Subclinical tuberculosis in children: diagnostic strategies for identification reported in a 6-year national prospective surveillance study.
    Clin Infect Dis. 2021 Aug 19. pii: 6354867. doi: 10.1093.
    PubMed     Abstract available


  47. LEWIS JM, Mphasa M, Keyala L, Banda R, et al
    A longitudinal observational study of aetiology and long-term outcomes of sepsis in Malawi revealing the key role of disseminated tuberculosis.
    Clin Infect Dis. 2021 Aug 18. pii: 6354427. doi: 10.1093.
    PubMed     Abstract available


  48. BURKE RM, Gupta Wright A
    Diagnosing Tuberculosis in People With Advanced Human Immunodeficiency Virus: More Is Needed.
    Clin Infect Dis. 2021;73:e878-e879.
    PubMed    


  49. MATOGA MM, Bisson GP, Gupta A, Miyahara S, et al
    Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy.
    Clin Infect Dis. 2021;73:e870-e877.
    PubMed     Abstract available


  50. KENDALL MA, Lalloo U, Fletcher CV, Wu X, et al
    Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection.
    Clin Infect Dis. 2021;73:706-715.
    PubMed     Abstract available


    July 2021
  51. KIM S, Cohen T, Horsburgh CR, Miller JW, et al
    Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States.
    Clin Infect Dis. 2021 Jul 29. pii: 6330597. doi: 10.1093.
    PubMed     Abstract available


  52. MATHAD JS, Savic R, Britto P, Jayachandran P, et al
    Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.
    Clin Infect Dis. 2021 Jul 29. pii: 6330598. doi: 10.1093.
    PubMed     Abstract available


  53. MOODLEY N, Velen K, Saimen A, Zakhura N, et al
    Digital chest radiography enhances screening efficiency for pulmonary tuberculosis in primary health clinics, South Africa.
    Clin Infect Dis. 2021 Jul 27. pii: 6329140. doi: 10.1093.
    PubMed     Abstract available


  54. KAY AW, Sandoval M, Mtetwa G, Mkhabela M, et al
    Vikela Ekhaya: a novel, community-based, tuberculosis contact management program in a high burden setting.
    Clin Infect Dis. 2021 Jul 24. pii: 6327779. doi: 10.1093.
    PubMed     Abstract available


  55. RADTKE KK, Hesseling AC, Winckler JL, Draper HR, et al
    Moxifloxacin pharmacokinetics, cardiac safety, and dosing for the treatment of rifampicin-resistant tuberculosis in children.
    Clin Infect Dis. 2021 Jul 21. pii: 6324883. doi: 10.1093.
    PubMed     Abstract available


  56. TAVAZIVA G, Harris M, Abidi SK, Geric C, et al
    Chest X-ray analysis with deep learning-based software as a triage test for pulmonary tuberculosis: an individual patient data meta-analysis of diagnostic accuracy.
    Clin Infect Dis. 2021 Jul 21. pii: 6324830. doi: 10.1093.
    PubMed     Abstract available


  57. WEIR IR, Wasserman S
    Treatment effect measures for culture conversion endpoints in phase IIb tuberculosis treatment trials.
    Clin Infect Dis. 2021 Jul 13. pii: 6319902. doi: 10.1093.
    PubMed     Abstract available


  58. PEETLUK LS, Rebeiro PF, Ridolfi FM, Andrade BB, et al
    A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes.
    Clin Infect Dis. 2021 Jul 2. pii: 6313211. doi: 10.1093.
    PubMed     Abstract available


  59. BAIK Y, Hanrahan CF, Mmolawa L, Nonyane BAS, et al
    Conditional cash transfers to incentivize tuberculosis screening: Description of a novel strategy for contact investigation in rural South Africa.
    Clin Infect Dis. 2021 Jul 2. pii: 6312933. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  60. CHU AL, Murray MB, Huang CC
    Potential role of latent tuberculosis infection in the pathophysiology of cardiovascular disease.
    Clin Infect Dis. 2021 Jun 28. pii: 6310818. doi: 10.1093.
    PubMed    


  61. CEGIELSKI JP, Udwadia ZF, Viiklepp P, Yim JJ, et al
    Reply to van Deun and Decroo.
    Clin Infect Dis. 2021;72:e1168-e1169.
    PubMed    


  62. CHIDAMBARAM V, Tun NL, Majella MG, Ruelas Castillo J, et al
    Male sex is associated with worse microbiological and clinical outcomes following tuberculosis treatment: A retrospective cohort study, a systematic review of the literature, and meta-analysis.
    Clin Infect Dis. 2021 Jun 8. pii: 6294896. doi: 10.1093.
    PubMed     Abstract available


  63. LU P, Liu Q, Zhou Y, Martinez L, et al
    Predictors of Discordant Tuberculin Skin Test and QuantiFERON-TB Gold In-tube Results in Eastern China: A Population-based, Cohort Study.
    Clin Infect Dis. 2021;72:2006-2015.
    PubMed     Abstract available


    May 2021
  64. CHU AL, Lecca LW, Calderon RI, Contreras CC, et al
    Smoking cessation in tuberculosis patients and the risk of tuberculosis infection in child household contacts.
    Clin Infect Dis. 2021 May 28. pii: 6287936. doi: 10.1093.
    PubMed     Abstract available


  65. XU M, Lu W, Li T, Li J, et al
    Sensitivity, specificity, and safety of a novel ESAT6-CFP10 skin test for tuberculosis infection in China: two randomized, self-controlled, parallel-group phase 2b trials.
    Clin Infect Dis. 2021 May 22. pii: 6280234. doi: 10.1093.
    PubMed     Abstract available


  66. LEE H, Myung W, Lee EM, Kim H, et al
    Mortality and Prognostic Factors of Nontuberculous Mycobacterial Infection in Korea: A Population-based Comparative Study.
    Clin Infect Dis. 2021;72:e610-e619.
    PubMed     Abstract available


  67. MALIK AA, Becerra MC, Lash TL, Cranmer LM, et al
    Risk Factors for Adverse Events in Household Contacts Prescribed Preventive Treatment for Drug-resistant Tuberculosis Exposure.
    Clin Infect Dis. 2021;72:1709-1715.
    PubMed     Abstract available


  68. NARITA M, Hatt G, Toren KG, Vuong K, et al
    Delayed Tuberculosis Diagnoses During the COVID-19 Pandemic in 2020 - King County, Washington.
    Clin Infect Dis. 2021 May 6. pii: 6270740. doi: 10.1093.
    PubMed    


  69. MARAIS BJ
    Improved Urine Lipoarabinomannan (LAM) Tests: The Answer for Child Tuberculosis Diagnosis?
    Clin Infect Dis. 2021;72:e289-e290.
    PubMed    


    April 2021
  70. GROBBEL HP, Merker M, Kohler N, Andres S, et al
    Design of multidrug-resistant tuberculosis treatment regimens based on DNA sequencing.
    Clin Infect Dis. 2021 Apr 26. pii: 6253713. doi: 10.1093.
    PubMed     Abstract available


  71. BRUST JCM, Gandhi NR, Wasserman S, Maartens G, et al
    Effectiveness and cardiac safety of bedaquiline-based therapy for drug-resistant tuberculosis: a prospective cohort study.
    Clin Infect Dis. 2021 Apr 21. pii: 6244470. doi: 10.1093.
    PubMed     Abstract available


  72. HWANG H, Kang H, Kwon YS, Jeon D, et al
    Outcomes of multidrug-resistant tuberculosis treated with bedaquiline or delamanid.
    Clin Infect Dis. 2021 Apr 10. pii: 6219782. doi: 10.1093.
    PubMed     Abstract available


  73. MARAIS BJ
    Good Outcomes in Babies With In Utero Bedaquiline Exposure.
    Clin Infect Dis. 2021;72:1169-1170.
    PubMed    


    March 2021
  74. BALIASHVILI D, Gandhi NR, Kim S, Hughes M, et al
    Resistance to Mycobacterium tuberculosis infection among household contacts: a multinational study.
    Clin Infect Dis. 2021 Mar 27. pii: 6193424. doi: 10.1093.
    PubMed     Abstract available


  75. ADU-GYAMFI C, Savulescu D, Mikhathani L, Otwombe K, et al
    Plasma kynurenine-to-tryptophan ratio, a highly sensitive blood-based diagnostic tool for Tuberculosis in HIV-infected pregnant women.
    Clin Infect Dis. 2021 Mar 15. pii: 6170938. doi: 10.1093.
    PubMed     Abstract available


  76. CRESSWELL FV, Meya DB, Kagimu E, Grint D, et al
    High-dose oral and intravenous rifampicin for the treatment of tuberculous meningitis in predominantly HIV-positive Ugandan adults: a phase II open-label randomised controlled trial.
    Clin Infect Dis. 2021 Mar 8. pii: 6159697. doi: 10.1093.
    PubMed     Abstract available


  77. HUANG HL, Huang WC, Lin KD, Liu SS, et al
    Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients with Poorly Controlled Diabetic Mellitus: A Prospective Multicenter Study.
    Clin Infect Dis. 2021 Mar 3. pii: 6157057. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  78. BURKE RM, Gupta Wright A
    Diagnosing tuberculosis in people with advanced HIV: more is needed.
    Clin Infect Dis. 2021 Feb 26. pii: 6152006. doi: 10.1093.
    PubMed    


  79. ACHARYA MP, Pradeep SP, Murthy VS, Chikkannaiah P, et al
    CD38 +CD27 -TNF-alpha + on Mtb-specific CD4 + T is a robust biomarker for tuberculosis diagnosis.
    Clin Infect Dis. 2021 Feb 19. pii: 6144985. doi: 10.1093.
    PubMed     Abstract available


  80. SAM-AGUDU NA, Rabie H, Pipo MT, Byamungu LN, et al
    The Critical Need for Pooled Data on COVID-19 in African Children: An AFREhealth Call for Action through Multi-Country Research Collaboration.
    Clin Infect Dis. 2021 Feb 13. pii: 6134449. doi: 10.1093.
    PubMed     Abstract available


  81. DU PREEZ K, Osman M, Seddon JA, Naidoo P, et al
    The impact of the evolving HIV response on the epidemiology of tuberculosis in South African children and adolescents.
    Clin Infect Dis. 2021 Feb 3. pii: 6127007. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  82. GUNASEKERA KS, Walters E, van der Zalm MM, Palmer M, et al
    Development of a treatment-decision algorithm for HIV-uninfected children evaluated for pulmonary tuberculosis.
    Clin Infect Dis. 2021 Jan 15. pii: 6101512. doi: 10.1093.
    PubMed     Abstract available


  83. BROGER T, Nicol MP
    A novel bedside rule-in test for tuberculous meningitis in HIV-infected adults.
    Clin Infect Dis. 2021 Jan 6. pii: 6065103. doi: 10.1093/cid/ciaa1915.
    PubMed    


  84. HUAMAN MA, De Cecco CN, Bittencourt MS, Ticona E, et al
    Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda.
    Clin Infect Dis. 2021 Jan 3. pii: 6060062. doi: 10.1093/cid/ciaa1934.
    PubMed     Abstract available


  85. QUINN CM, Kagimu E, Okirworth M, Bangdiwala AS, et al
    Fujifilm SILVAMP TB LAM assay on cerebrospinal fluid for the detection of tuberculous meningitis in HIV-infected adults.
    Clin Infect Dis. 2021 Jan 3. pii: 6059780. doi: 10.1093/cid/ciaa1910.
    PubMed     Abstract available


    December 2020
  86. TACK I, Dumicho A, Ohler L, Shigayeva A, et al
    Safety and effectiveness of an all-oral, bedaquiline-based, shorter treatment regimen for rifampicin-resistant tuberculosis in high HIV burden rural South Africa: a retrospective cohort analysis.
    Clin Infect Dis. 2020 Dec 29. pii: 6054965. doi: 10.1093/cid/ciaa1894.
    PubMed     Abstract available


  87. VAN DEUN A, Decroo T
    How second-line injectable drugs work.
    Clin Infect Dis. 2020 Dec 20. pii: 6042343. doi: 10.1093/cid/ciaa1874.
    PubMed    


  88. YUEN CM, Majidulla A, Jaswal M, Safdar N, et al
    Cost of delivering 12-dose isoniazid and rifapentine versus 6 months of isoniazid for tuberculosis infection in a high-burden setting.
    Clin Infect Dis. 2020 Dec 8. pii: 6025518. doi: 10.1093/cid/ciaa1835.
    PubMed     Abstract available


  89. OH CE, Ortiz-Brizuela E, Bastos ML, Menzies D, et al
    Comparing the Diagnostic Performance of QFT-Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2020 Dec 8. pii: 6026460. doi: 10.1093/cid/ciaa1822.
    PubMed     Abstract available


  90. DONOVAN J, Oanh PKN, Dobbs N, Phu NH, et al
    Optic nerve sheath ultrasound for the detection and monitoring of raised intracranial pressure in tuberculous meningitis.
    Clin Infect Dis. 2020 Dec 7. pii: 6025000. doi: 10.1093/cid/ciaa1823.
    PubMed     Abstract available


  91. KENDALL EA, Kitonsa PJ, Nalutaaya A, Kamoga CE, et al
    The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities.
    Clin Infect Dis. 2020 Dec 6. pii: 6024999. doi: 10.1093/cid/ciaa1824.
    PubMed     Abstract available


  92. WONG EB
    It is time to focus on asymptomatic tuberculosis.
    Clin Infect Dis. 2020 Dec 6. pii: 6024996. doi: 10.1093/cid/ciaa1827.
    PubMed    


  93. VAN TOORN R, Solomons RS, Seddon JA, Schoeman JF, et al
    Thalidomide use for complicated central nervous system tuberculosis in children: insights from an observational cohort.
    Clin Infect Dis. 2020 Dec 6. pii: 6024997. doi: 10.1093/cid/ciaa1826.
    PubMed     Abstract available


    November 2020
  94. ASABOR EN, Vermund SH
    Confronting structural racism in the prevention and control of tuberculosis in the United States.
    Clin Infect Dis. 2020 Nov 26. pii: 6006871. doi: 10.1093/cid/ciaa1763.
    PubMed     Abstract available


  95. HUANG HL, Lee MR, Cheng MH, Lu PL, et al
    Impact of age on outcome of rifapentine-based weekly therapy for latent tuberculosis infection.
    Clin Infect Dis. 2020 Nov 19. pii: 5992466. doi: 10.1093/cid/ciaa1741.
    PubMed     Abstract available


  96. REDDY KP, Denkinger CM, Broger T, McCann NC, et al
    Cost-effectiveness of a novel lipoarabinomannan test for tuberculosis in patients with HIV.
    Clin Infect Dis. 2020 Nov 17. pii: 5983890. doi: 10.1093/cid/ciaa1698.
    PubMed     Abstract available


  97. MONTEPIEDRA G, Kim S, Weinberg A, Theron G, et al
    Using a composite maternal-infant outcome measure in tuberculosis prevention studies among pregnant women.
    Clin Infect Dis. 2020 Nov 4. pii: 5955952. doi: 10.1093/cid/ciaa1674.
    PubMed     Abstract available


  98. COLLINS JM, Stout JE, Ayers T, Hill AN, et al
    Prevalence of Latent Tuberculosis Infection among Non-U.S.-Born Persons by Country of Birth - United States, 2012-2017.
    Clin Infect Dis. 2020 Nov 2. pii: 5952274. doi: 10.1093/cid/ciaa1662.
    PubMed     Abstract available


    October 2020
  99. CEGIELSKI JP, Chan PC, Lan Z, Udwadia ZF, et al
    Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016.
    Clin Infect Dis. 2020 Oct 30. pii: 5943503. doi: 10.1093.
    PubMed     Abstract available


  100. ZHENG X, Bao Z, Forsman LD, Hu Y, et al
    Drug exposure and minimum inhibitory concentration predict pulmonary tuberculosis treatment response.
    Clin Infect Dis. 2020 Oct 18. pii: 5929670. doi: 10.1093/cid/ciaa1569.
    PubMed     Abstract available


  101. KAKAIRE R, Kiwanuka N, Zalwango S, Sekandi JN, et al
    Excess Risk of Tuberculous Infection among Extra-Household Contacts of Tuberculosis Cases in an African City.
    Clin Infect Dis. 2020 Oct 16. pii: 5925052. doi: 10.1093/cid/ciaa1556.
    PubMed     Abstract available


  102. DUFFY D, Nemes E, Llibre A, Rouilly V, et al
    Immune profiling enables stratification of patients with active TB disease or M. tuberculosis infection.
    Clin Infect Dis. 2020 Oct 16. pii: 5924452. doi: 10.1093/cid/ciaa1562.
    PubMed     Abstract available


  103. ZELNICK JR, Daftary A, Hwang C, Labar AS, et al
    Electronic dose monitoring identifies a high-risk subpopulation in the treatment of drug-resistant tuberculosis and HIV.
    Clin Infect Dis. 2020 Oct 14. pii: 5923372. doi: 10.1093/cid/ciaa1557.
    PubMed     Abstract available


  104. KUHLIN J, Davies Forsman L, Mansjo M, Jonsson Nordvall M, et al
    Genotypic resistance of pyrazinamide but not MIC is associated with longer time to sputum culture conversion in patients with multidrug-resistant tuberculosis.
    Clin Infect Dis. 2020 Oct 3. pii: 5917759. doi: 10.1093/cid/ciaa1509.
    PubMed     Abstract available


    September 2020
  105. THERON G, Montepiedra G, Aaron L, McCarthy K, et al
    Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With HIV.
    Clin Infect Dis. 2020 Sep 30. pii: 5913421. doi: 10.1093/cid/ciaa1482.
    PubMed     Abstract available


  106. MARTYN EM, Bangdiwala AS, Kagimu E, Rutakingirwa MK, et al
    Cerebrospinal fluid bacillary load by Xpert MTB/RIF Ultra PCR Cycle Threshold value predicts two-week mortality in HIV-associated tuberculous meningitis.
    Clin Infect Dis. 2020 Sep 28. pii: 5912549. doi: 10.1093/cid/ciaa1444.
    PubMed     Abstract available


  107. CHIDAMBARAM V, Gupte A, Wang JY, Golub JE, et al
    The Impact of Hypertension and Use of Calcium Channel Blockers on Tuberculosis Treatment Outcomes.
    Clin Infect Dis. 2020 Sep 24. pii: 5911212. doi: 10.1093/cid/ciaa1446.
    PubMed     Abstract available


  108. FRASCELLA B, Richards AS, Sossen B, Emery JC, et al
    Subclinical tuberculosis disease - a review and analysis of prevalence surveys to inform definitions, burden, associations and screening methodology.
    Clin Infect Dis. 2020 Sep 16. pii: 5906549. doi: 10.1093/cid/ciaa1402.
    PubMed     Abstract available


  109. DOOKIE N, Padayatchi N, Naidoo K
    Tuberculosis Elimination in the Era of COVID-19: A Moving Target.
    Clin Infect Dis. 2020 Sep 14. pii: 5905579. doi: 10.1093/cid/ciaa1400.
    PubMed    


  110. HAAS MK, Aiona K, Erlandson KM, Belknap RW, et al
    Higher Completion Rates with Self-administered Once-weekly Isoniazid-Rifapentine versus Daily Rifampin in Adults with Latent Tuberculosis.
    Clin Infect Dis. 2020 Sep 11. pii: 5904201. doi: 10.1093/cid/ciaa1364.
    PubMed     Abstract available


    August 2020
  111. LIU Q, Lu P, Shen Y, Li C, et al
    Collateral Impact of the Covid-19 Pandemic on Tuberculosis Control in Jiangsu Province, China.
    Clin Infect Dis. 2020 Aug 28. pii: 5898659. doi: 10.1093/cid/ciaa1289.
    PubMed     Abstract available


  112. PASIPANODYA J, Gumbo T
    The relationship between drug concentration in tuberculosis lesions, epithelial lining fluid, and clinical outcomes.
    Clin Infect Dis. 2020 Aug 28. pii: 5898607. doi: 10.1093/cid/ciaa1271.
    PubMed    


  113. MCCALLUM AD, Pertinez HE, Else LJ, Dilly-Penchala S, et al
    Intrapulmonary pharmacokinetics of first-line anti-TB drugs in Malawian tuberculosis patients.
    Clin Infect Dis. 2020 Aug 28. pii: 5898506. doi: 10.1093/cid/ciaa1265.
    PubMed     Abstract available


  114. MOOSA MS, Maartens G, Gunter H, Allie S, et al
    A Randomized Controlled Trial of Intravenous N-acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury.
    Clin Infect Dis. 2020 Aug 26. pii: 5897464. doi: 10.1093/cid/ciaa1255.
    PubMed     Abstract available


  115. ROMANOWSKI K, Sobkowiak B, Guthrie JL, Cook VJ, et al
    Using Whole Genome Sequencing to Determine the Timing of Secondary Tuberculosis in British Columbia, Canada.
    Clin Infect Dis. 2020 Aug 19. pii: 5894147. doi: 10.1093/cid/ciaa1224.
    PubMed     Abstract available


  116. CAMPBELL JR, Al-Jahdali H, Bah B, Belo M, et al
    Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials.
    Clin Infect Dis. 2020 Aug 12. pii: 5891810. doi: 10.1093/cid/ciaa1169.
    PubMed     Abstract available


  117. MARTINEZ L, Woldu H, Chen C, Hallowell BD, et al
    Transmission Dynamics in Tuberculosis Patients with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis of 32 Observational Studies.
    Clin Infect Dis. 2020 Aug 8. pii: 5889983. doi: 10.1093/cid/ciaa1146.
    PubMed     Abstract available


  118. KUMAR NP, Moideen K, Nancy A, Viswanathan V, et al
    Plasma chemokines are baseline predictors of unfavorable treatment outcomes in pulmonary tuberculosis.
    Clin Infect Dis. 2020 Aug 7. pii: 5885172. doi: 10.1093/cid/ciaa1104.
    PubMed     Abstract available


  119. RAGONNET R, Flegg JA, Brilleman SL, Tiemersma EW, et al
    Revisiting the Natural History of Pulmonary Tuberculosis: a Bayesian Estimation of Natural Recovery and Mortality rates.
    Clin Infect Dis. 2020 Aug 7. pii: 5882189. doi: 10.1093.
    PubMed     Abstract available


  120. NICOL MP, Schumacher SG, Workman L, Broger T, et al
    Accuracy of a novel urine test, Fujifilm SILVAMP TB LAM, for the diagnosis of pulmonary tuberculosis in children.
    Clin Infect Dis. 2020 Aug 6. pii: 5881994. doi: 10.1093/cid/ciaa1052.
    PubMed     Abstract available


  121. PETTIT AC, Stout JE, Belknap R, Benson CA, et al
    Optimal testing choice and diagnostic strategies for latent tuberculosis infection among U.S.-born people living with HIV.
    Clin Infect Dis. 2020 Aug 6. pii: 5881730. doi: 10.1093/cid/ciaa1135.
    PubMed     Abstract available


    July 2020
  122. YOSHIYAMA T, Mitarai S, Takaki A, Aono A, et al
    Multi-drug resistant tuberculosis with simultaneously acquired-drug resistance to bedaquiline and delamanid.
    Clin Infect Dis. 2020 Jul 30. pii: 5879015. doi: 10.1093/cid/ciaa1064.
    PubMed     Abstract available


  123. WEINBERG A, Aaron L, Montepiedra G, Sterling TR, et al
    Effects of Pregnancy and Isoniazid Preventive Therapy on M. tuberculosis Interferon Gamma Response Assays in Women with HIV.
    Clin Infect Dis. 2020 Jul 28. pii: 5877271. doi: 10.1093/cid/ciaa1083.
    PubMed     Abstract available


  124. LIU Y, Gao M, Du J, Wang L, et al
    Reduced susceptibility of Mycobacterium tuberculosis to bedaquiline during antituberculosis treatment and its correlation with clinical outcomes in China.
    Clin Infect Dis. 2020 Jul 15. pii: 5871905. doi: 10.1093/cid/ciaa1002.
    PubMed     Abstract available


  125. MIRANDA C, Bark CM
    TB, or not TB, the Choice Is Ours.
    Clin Infect Dis. 2020;71:291-292.
    PubMed    


  126. BOLD TD, Cheng MP, Marty FM
    Reply to Singh.
    Clin Infect Dis. 2020;71:471-472.
    PubMed    


  127. SHU CC, Tsai MK, Lin SW, Wang JY, et al
    Latent Tuberculosis Infection Increases in Kidney Transplantation Recipients Compared With Transplantation Candidates: A Neglected Perspective in Tuberculosis Control.
    Clin Infect Dis. 2020 Jul 4. pii: 5867272. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  128. BISIMWA BC, Nachega JB, Warren RM, Theron G, et al
    Xpert MTB/RIF-detected Rifampicin Resistance is a Sub-Optimal Surrogate for Multidrug Resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
    Clin Infect Dis. 2020 Jun 26. pii: 5863452. doi: 10.1093.
    PubMed     Abstract available


  129. MARTINEZ L, Andrews JR
    Identifying priorities for testing and treatment of latent tuberculosis infection in the United States.
    Clin Infect Dis. 2020 Jun 26. pii: 5863155. doi: 10.1093.
    PubMed    


  130. NARDELL EA
    Time to revise our tuberculosis infection-latency-disease model in high-burden settings.
    Clin Infect Dis. 2020 Jun 25. pii: 5862697. doi: 10.1093.
    PubMed    


  131. JO Y, Shrestha S, Gomes I, Marks S, et al
    Model-Based Cost-Effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York and Texas.
    Clin Infect Dis. 2020 Jun 25. pii: 5862678. doi: 10.1093.
    PubMed     Abstract available


  132. JIANG Q, Liu Q, Ji L, Li J, et al
    Citywide Transmission of Multidrug-resistant Tuberculosis Under China's Rapid Urbanization: A Retrospective Population-based Genomic Spatial Epidemiological Study.
    Clin Infect Dis. 2020;71:142-151.
    PubMed     Abstract available


  133. LACOURSE SM, Richardson BA, Kinuthia J, Warr AJ, et al
    A randomized controlled trial of isoniazid to prevent Mycobacterium tuberculosis infection in Kenyan HIV-exposed uninfected infants.
    Clin Infect Dis. 2020 Jun 21. pii: 5860476. doi: 10.1093.
    PubMed     Abstract available


  134. PUYAT JH, Shulha HP, Balshaw R, Campbell JR, et al
    How well does TSTin3D predict risk of active tuberculosis in the Canadian immigrant population? An External Validation Study.
    Clin Infect Dis. 2020 Jun 18. pii: 5859579. doi: 10.1093.
    PubMed     Abstract available


  135. DONOVAN J, Cresswell FV, Thuong NTT, Boulware DR, et al
    Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward.
    Clin Infect Dis. 2020 Jun 16. pii: 5858077. doi: 10.1093.
    PubMed     Abstract available


  136. ECKOLD C, Kumar V, Weiner Rd J, Alisjahbana B, et al
    Impact of intermediate hyperglycaemia as well as diabetes on immune dysfunction in tuberculosis.
    Clin Infect Dis. 2020 Jun 13. pii: 5857148. doi: 10.1093.
    PubMed     Abstract available


  137. WILKINSON RJ
    Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19.
    Clin Infect Dis. 2020 Jun 13. pii: 5857156. doi: 10.1093.
    PubMed    


  138. FOX GJ, Redwood L, Chang V, Ho J, et al
    The effectiveness of individual and environmental infection control measures in reducing the transmission of Mycobacterium tuberculosis: a systematic review.
    Clin Infect Dis. 2020 Jun 5. pii: 5853999. doi: 10.1093.
    PubMed     Abstract available


  139. KARAT AS, Gregg M, Barton HE, Calderon M, et al
    Evidence for the use of triage, respiratory isolation, and effective treatment to reduce the transmission of Mycobacterium tuberculosis in health care settings: a systematic review.
    Clin Infect Dis. 2020 Jun 5. pii: 5852552. doi: 10.1093.
    PubMed     Abstract available


  140. GRIFFITH DE, Cegielski JP
    Tuberculosis Healthcare Workers: There Goes My Hero.
    Clin Infect Dis. 2020 Jun 5. pii: 5853603. doi: 10.1093.
    PubMed    


    May 2020
  141. GAENSBAUER J
    Xpert Ultra assay on children's stool to diagnose pulmonary tuberculosis.
    Clin Infect Dis. 2020 May 25. pii: 5843708. doi: 10.1093.
    PubMed    


  142. CHIANG SS, Brooks MB, Jenkins HE, Rubenstein D, et al
    Concordance of drug resistance profiles between persons with drug-resistant tuberculosis and their household contacts: a systematic review and meta-analysis.
    Clin Infect Dis. 2020 May 25. pii: 5843623. doi: 10.1093.
    PubMed     Abstract available


  143. KABIR S, Rahman SMM, Ahmed S, Islam MS, et al
    Xpert Ultra assay on stool to diagnose pulmonary tuberculosis in children.
    Clin Infect Dis. 2020 May 18. pii: 5839814. doi: 10.1093.
    PubMed     Abstract available


  144. WALLES J, Tesfaye F, Jansson M, Balcha TT, et al
    Tuberculosis infection in women of reproductive age - a cross-sectional study at antenatal care clinics in an Ethiopian city.
    Clin Infect Dis. 2020 May 15. pii: 5837526. doi: 10.1093.
    PubMed     Abstract available


  145. SHIN SS, Modongo C, Zetola NM
    Twice-Daily vs. Once-Daily Dolutegravir in Patients With Human Immunodeficiency Virus-Tuberculosis Coinfection Receiving Rifampicin-Based Tuberculosis Therapy.
    Clin Infect Dis. 2020 May 14. pii: 5836979. doi: 10.1093.
    PubMed    


  146. DOOKIE N, Padayatchi N, Lessells RJ, Naicker CL, et al
    Individualised treatment of Multi-Drug Resistant Tuberculosis using Whole Genome Sequencing and Expanded Drug Susceptibility Testing.
    Clin Infect Dis. 2020 May 8. pii: 5834727. doi: 10.1093.
    PubMed     Abstract available


  147. PURYEAR SB, Fatch R, Beesiga B, Kekibiina A, et al
    Higher levels of alcohol use are associated with latent tuberculosis infection in adults living with HIV.
    Clin Infect Dis. 2020 May 6. pii: 5831355. doi: 10.1093.
    PubMed     Abstract available


  148. HORSBURGH CR
    "Plus Ca Change...".
    Clin Infect Dis. 2020;70:2119-2120.
    PubMed    


    April 2020
  149. MARURI F, Guo Y, Blackman A, van der Heijden YF, et al
    Resistance-conferring mutations on whole-genome sequencing of fluoroquinolone-resistant and -susceptible M. tuberculosis isolates: a proposed threshold for identifying resistance.
    Clin Infect Dis. 2020 Apr 29. pii: 5827013. doi: 10.1093.
    PubMed     Abstract available


  150. HERMANS SM, Zinyakatira N, Caldwell J, Cobelens FGJ, et al
    High rates of recurrent TB disease: a population-level cohort study.
    Clin Infect Dis. 2020 Apr 25. pii: 5825249. doi: 10.1093.
    PubMed     Abstract available


  151. BOARDMAN NJ, Moore T, Freiman J, Tagliaferri G, et al
    Pulmonary tuberculosis disease among immigrant detainees: rapid disease detection, high prevalence of asymptomatic disease and implications for tuberculosis prevention.
    Clin Infect Dis. 2020 Apr 16. pii: 5820624. doi: 10.1093.
    PubMed     Abstract available


  152. BOUTON TC, Jacobson KR
    Symptom screens are not sufficient: the fight against tuberculosis needs better weapons.
    Clin Infect Dis. 2020 Apr 16. pii: 5820627. doi: 10.1093.
    PubMed    


  153. ALVAREZ GG, Zwerling AA, Duncan C, Pease C, et al
    Molecular epidemiology of Mycobacterium tuberculosis to describe the transmission dynamics among Inuit residing in Iqaluit Nunavut using whole genome sequencing.
    Clin Infect Dis. 2020 Apr 13. pii: 5819740. doi: 10.1093.
    PubMed     Abstract available


  154. ALFFENAAR JC, Gumbo T, Dooley KE, Peloquin CA, et al
    Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis.
    Clin Infect Dis. 2020;70:1774-1780.
    PubMed     Abstract available


  155. REUTER A, Furin J
    Treating drug-resistant tuberculosis infection: no more excuses.
    Clin Infect Dis. 2020 Apr 8. pii: 5817606. doi: 10.1093.
    PubMed    


    March 2020
  156. THOMAS BE, Kumar JV, Chiranjeevi M, Shah D, et al
    Evaluation of the accuracy of 99DOTS, a novel cellphone-based strategy for monitoring adherence to tuberculosis medications: Comparison of digital adherence data with urine isoniazid testing.
    Clin Infect Dis. 2020 Mar 28. pii: 5812993. doi: 10.1093.
    PubMed     Abstract available


  157. SCHMIT KM, Wortham JM, Ho CS, Powell KM, et al
    Analysis of severe adverse events reported among patients receiving isoniazid-rifapentine treatment for latent Mycobacterium tuberculosis infection - United States, 2012-2016.
    Clin Infect Dis. 2020 Mar 18. pii: 5809293. doi: 10.1093.
    PubMed     Abstract available


  158. SRINIVASAN V, Ha VTN, Vinh DN, Thai PVK, et al
    Sources of multi-drug resistance in patients with previous isoniazid resistant tuberculosis identified using whole genome sequencing: A longitudinal cohort study.
    Clin Infect Dis. 2020 Mar 13. pii: 5804256. doi: 10.1093.
    PubMed     Abstract available


  159. LOVEDAY M, Hughes J, Sunkari B, Master I, et al
    Maternal and infant outcomes among pregnant women treated for multidrug/rifampicin-resistant tuberculosis in South Africa.
    Clin Infect Dis. 2020 Mar 6. pii: 5788430. doi: 10.1093.
    PubMed     Abstract available


  160. CHENG MP, Marty FM
    Reply to Aronson et al.
    Clin Infect Dis. 2020;70:1262.
    PubMed    


    February 2020
  161. WOODMAN M, Grandjean L
    Detecting Tuberculosis in Prisons: Switching Off the Disease at its Source.
    Clin Infect Dis. 2020 Feb 17. pii: 5736587. doi: 10.1093.
    PubMed    


  162. SANTOS ADS, Oliveira RD, Lemos EF, Lima F, et al
    Yield, Efficiency and Costs of Mass Screening Algorithms for Tuberculosis in Brazilian Prisons.
    Clin Infect Dis. 2020 Feb 17. pii: 5736588. doi: 10.1093.
    PubMed     Abstract available


  163. REICHLER MR, Khan A, Yuan Y, Chen B, et al
    Duration of Exposure Among Close Contacts of Patients With Infectious Tuberculosis and Risk of Latent Tuberculosis Infection.
    Clin Infect Dis. 2020 Feb 11. pii: 5733747. doi: 10.1093/cid/ciz1044.
    PubMed     Abstract available


  164. VAN DER WERF MJ, Rosales-Klintz S, de Vlas SJ
    Screening for Latent Tuberculosis (TB) Infection in Low TB Incidence Countries.
    Clin Infect Dis. 2020;70:716-717.
    PubMed    


  165. MIYAHARA S, Ramchandani R, Kim S, Evans SR, et al
    Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials.
    Clin Infect Dis. 2020;70:698-703.
    PubMed     Abstract available


    January 2020
  166. KORNFELD H, Sahukar SB, Procter-Gray E, Kumar NP, et al
    Impact of Diabetes and Low Body Mass Index on Tuberculosis Treatment Outcomes.
    Clin Infect Dis. 2020 Jan 19. pii: 5709634. doi: 10.1093.
    PubMed     Abstract available


  167. UGARTE-GIL C, Pearson F, Moore D, Critchley J, et al
    Reply to Yates and Barr.
    Clin Infect Dis. 2020;70:545-546.
    PubMed    


  168. HONG H, Dowdy DW
    Reply to Chen, Song, and Liu.
    Clin Infect Dis. 2020;70:547-548.
    PubMed    


  169. CHEN HL, Song YP, Liu K
    Prediction Model Needs More Improvements Before Clinical Application.
    Clin Infect Dis. 2020;70:546-547.
    PubMed    


  170. PARK JH, Choi EJ, Park HS, Choi SH, et al
    Treatment of latent tuberculosis infection based on the interferon-gamma releasing assay in allogeneic stem cell transplant recipients.
    Clin Infect Dis. 2020 Jan 13. pii: 5701499. doi: 10.1093.
    PubMed     Abstract available


  171. SOSSEN B, Broger T, Kerkhoff AD, Schutz C, et al
    'SILVAMP TB LAM' rapid urine tuberculosis test predicts mortality in hospitalized HIV patients in South Africa.
    Clin Infect Dis. 2020 Jan 9. pii: 5699650. doi: 10.1093.
    PubMed     Abstract available


  172. LI R, Nordio F, Huang CC, Contreras C, et al
    Two clinical prediction tools to improve tuberculosis contact investigation.
    Clin Infect Dis. 2020 Jan 6. pii: 5697300. doi: 10.1093/cid/ciz1221.
    PubMed     Abstract available


  173. RENS NE, Uyl-de Groot CA, Goldhaber-Fiebert JD, Croda J, et al
    Cost-Effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active Tuberculosis.
    Clin Infect Dis. 2020 Jan 6. pii: 5697286. doi: 10.1093/cid/ciz1212.
    PubMed     Abstract available


    December 2019
  174. BOGLIONE L, Lipani F, Lucchini AM, Salvador E, et al
    Antiviral therapy in patients with HBV treated for tuberculosis: a forgotten issue.
    Clin Infect Dis. 2019 Dec 17. pii: 5679635. doi: 10.1093/cid/ciz1199.
    PubMed    


  175. KENDALL EA, Malhotra S, Cook-Scalise S, Dowdy DW, et al
    Clinical impact of rapid drug susceptibility testing to accompany fluoroquinolone-containing universal tuberculosis regimens: a Markov model.
    Clin Infect Dis. 2019 Dec 9. pii: 5669959. doi: 10.1093/cid/ciz1179.
    PubMed     Abstract available


  176. NOGUERA-JULIAN A, Calzada-HernAndez J, Brinkmann F, Basu Roy R, et al
    Tuberculosis disease in children and adolescents on therapy with anti-tumor necrosis factor-alpha agents: a collaborative, multi-centre ptbnet study.
    Clin Infect Dis. 2019 Dec 4. pii: 5651260. doi: 10.1093/cid/ciz1138.
    PubMed     Abstract available


  177. NOLT D
    Granulomas and guidelines - the search for tuberculosis during TNF-alpha inhibition.
    Clin Infect Dis. 2019 Dec 4. pii: 5651255. doi: 10.1093/cid/ciz1139.
    PubMed    


    November 2019
  178. GUPTA-WRIGHT A, Fielding K, Wilson D, van Oosterhout JJ, et al
    Tuberculosis in hospitalised patients with HIV: clinical characteristics, mortality, and implications from the STAMP trial.
    Clin Infect Dis. 2019 Nov 29. pii: 5645290. doi: 10.1093/cid/ciz1133.
    PubMed     Abstract available


  179. WALSH KF, Koenig SP
    Missed Opportunities with Fatal Consequences: The Need for Earlier Initiation of Intensified Care for Patients at Highest Risk of Mortality from HIV-Associated Tuberculosis.
    Clin Infect Dis. 2019 Nov 29. pii: 5645295. doi: 10.1093/cid/ciz1134.
    PubMed    


  180. FLYNN AG, Aiona K, Haas MK, Reves R, et al
    Clinical Characteristics of Active Tuberculosis Diagnosed after Starting Treatment for Latent Tuberculosis Infection.
    Clin Infect Dis. 2019 Nov 27. pii: 5644105. doi: 10.1093/cid/ciz1157.
    PubMed     Abstract available


  181. MANABE YC, Andrade BB, Gupte N, Leong S, et al
    A Parsimonious Host Inflammatory Biomarker Signature Predicts Incident TB and Mortality in Advanced HIV.
    Clin Infect Dis. 2019 Nov 25. pii: 5639757. doi: 10.1093/cid/ciz1147.
    PubMed     Abstract available


  182. RAVIMOHAN S, Maenetje P, Auld SC, Ncube I, et al
    A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis.
    Clin Infect Dis. 2019 Nov 22. pii: 5637499. doi: 10.1093.
    PubMed     Abstract available


  183. KEMPKER RR, Mikiashvili L, Zhao Y, Benkeser D, et al
    Clinical Outcomes among Patients with Drug-resistant Tuberculosis receiving Bedaquiline or Delamanid Containing Regimens.
    Clin Infect Dis. 2019 Nov 12. pii: 5622604. doi: 10.1093/cid/ciz1107.
    PubMed     Abstract available


  184. SEUNG KJ, Khan P, Franke MF, Ahmed S, et al
    Culture conversion at six months in patients receiving delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis.
    Clin Infect Dis. 2019 Nov 2. pii: 5611120. doi: 10.1093/cid/ciz1084.
    PubMed     Abstract available


    October 2019
  185. SVENSSON EM, Dian S, Te Brake L, Ganiem AR, et al
    Model-based meta-analysis of rifampicin exposure and mortality in Indonesian tuberculosis meningitis trials.
    Clin Infect Dis. 2019 Oct 30. pii: 5609415. doi: 10.1093/cid/ciz1071.
    PubMed     Abstract available


  186. SILVEIRA-MATTOS PS, Barreto-Duarte B, Vasconcelos B, Fukutani KF, et al
    Differential expression of activation markers by Mycobacterium tuberculosis-specific CD4+ T-cell distinguishes extrapulmonary from pulmonary tuberculosis and latent infection.
    Clin Infect Dis. 2019 Oct 30. pii: 5609412. doi: 10.1093/cid/ciz1070.
    PubMed     Abstract available


  187. KOENIG SP, Kim A, Shepherd BE, Cesar C, et al
    Increased Mortality after Tuberculosis Treatment Completion in Persons with HIV in Latin America.
    Clin Infect Dis. 2019 Oct 20. pii: 5601170. doi: 10.1093/cid/ciz1032.
    PubMed     Abstract available


  188. NAIDOO K, Hassan-Moosa R, Mlotshwa P, Yende-Zuma N, et al
    High Rates of Drug-induced Liver Injury in People Living With HIV Coinfected With Tuberculosis (TB) Irrespective of Antiretroviral Therapy Timing During Antituberculosis Treatment: Results From the Starting Antiretroviral Therapy at Three Points in TB
    Clin Infect Dis. 2019 Oct 17. pii: 5589114. doi: 10.1093.
    PubMed     Abstract available


  189. SINGH N
    Unique Rarity of Tuberculosis and Granulomatous Opportunistic Infections in Hematopoietic Cell Transplant Recipients.
    Clin Infect Dis. 2019 Oct 4. pii: 5581232. doi: 10.1093.
    PubMed    


    September 2019
  190. SHAH M, Paradis S, Betz J, Beylis N, et al
    Multicenter Study of the Accuracy of the BD MAX MDR-TB Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated with Resistance to Rifampin and Isoniazid.
    Clin Infect Dis. 2019 Sep 27. pii: 5574845. doi: 10.1093.
    PubMed     Abstract available


  191. KUBJANE M, Berkowitz N, Goliath R, Levitt NS, et al
    Tuberculosis, HIV and the association with transient hyperglycaemia in peri-urban South Africa.
    Clin Infect Dis. 2019 Sep 26. pii: 5574636. doi: 10.1093.
    PubMed     Abstract available


  192. MASE S, Chorba T, Parks S, Belanger A, et al
    Bedaquiline for the Treatment of Multidrug-Resistant Tuberculosis in the United States.
    Clin Infect Dis. 2019 Sep 26. pii: 5574390. doi: 10.1093.
    PubMed     Abstract available


  193. SWIFT MD, Molella RG, Vaughn AIS, Breeher LE, et al
    Determinants of Latent Tuberculosis Treatment Acceptance and Completion in Healthcare Personnel.
    Clin Infect Dis. 2019 Sep 25. pii: 5573404. doi: 10.1093.
    PubMed     Abstract available


  194. AULD SC, Maenetje P, Ravimohan S, Weissman D, et al
    Declines in Lung Function After Antiretroviral Therapy Initiation in Adults With Human Immunodeficiency Virus and Tuberculosis: A Potential Manifestation of Respiratory Immune Reconstitution Inflammatory Syndrome.
    Clin Infect Dis. 2019 Sep 25. pii: 5573460. doi: 10.1093.
    PubMed     Abstract available


  195. DU Y, Qiu C, Chen X, Wang J, et al
    Treatment outcome of a shorter regimen containing clofazimine for multidrug-resistant tuberculosis: a randomized control trial in China.
    Clin Infect Dis. 2019 Sep 24. pii: 5573036. doi: 10.1093.
    PubMed     Abstract available


  196. KENYON C, Peeters D, Goedgezelschap A, Vlieghe E, et al
    A Color-conscious Diagnosis.
    Clin Infect Dis. 2019;69:1259-1261.
    PubMed    


  197. MNGQIBISA R, Kendall MA, Dooley K, Wu X, et al
    Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate (DMPA) in African women receiving treatment for HIV and TB: Potential concern for standard dosing frequency.
    Clin Infect Dis. 2019 Sep 5. pii: 5561543. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  198. RAVIMOHAN S, Auld SC, Maenetje P, Ratsela N, et al
    Lung injury on antiretroviral therapy in adults with HIV/TB.
    Clin Infect Dis. 2019 Jun 26. pii: 5523721. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  199. THAO LTP, Wolbers M, Heemskerk AD, Thi Hoang Mai N, et al
    Dynamic prediction of death in patients with tuberculous meningitis using time-updated Glasgow coma score and plasma sodium measurements.
    Clin Infect Dis. 2019 Apr 4. pii: 5427068. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  200. ALFFENAAR JC, Heysell SK, Mpagama SG
    Therapeutic Drug Monitoring: The Need for Practical Guidance.
    Clin Infect Dis. 2019;68:1065-1066.
    PubMed    


    August 2018
  201. ROBERTSON K, Oladeji B, Jiang H, Kumwenda J, et al
    HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction.
    Clin Infect Dis. 2018 Aug 20. pii: 5076927. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  202. MOORE CC, Jacob ST, Banura P, Zhang J, et al
    Etiology of Sepsis in Uganda using a Quantitative PCR-based TaqMan Array Card.
    Clin Infect Dis. 2018 Jun 4. pii: 5032704. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  203. DIAN S, Rahmadi R, Laarhoven AV, Ganiem AR, et al
    Predicting mortality of tuberculous meningitis.
    Clin Infect Dis. 2018 May 31. pii: 5025876. doi: 10.1093.
    PubMed    


    April 2018
  204. VON REYN CF, Horsburgh CR
    Non-tuberculous mycobacteria and testing for LTBI.
    Clin Infect Dis. 2018 Apr 18. pii: 4975392. doi: 10.1093.
    PubMed    


    March 2018
  205. VAN LAARHOVEN A, Koeken VACM, Dian S, Ganiem AR, et al
    Neuromarker Levels Also Predict Mortality in Adult Tuberculous Meningitis.
    Clin Infect Dis. 2018 Mar 30. pii: 4956701. doi: 10.1093.
    PubMed    


  206. FRIGATI L, Archary M, Rabie H, Penazzato M, et al
    Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.
    Clin Infect Dis. 2018;66.
    PubMed     Abstract available


  207. FORD N, Meintjes G, Calmy A, Bygrave H, et al
    Managing Advanced HIV Disease in a Public Health Approach.
    Clin Infect Dis. 2018;66.
    PubMed     Abstract available


  208. SEKAGGYA-WILTSHIRE C, von Braun A, Lamorde M, Ledergerber B, et al
    Delayed Sputum Conversion in TB-HIV Co-Infected Patients with Low Isoniazid and Rifampicin Concentrations.
    Clin Infect Dis. 2018 Mar 3. pii: 4919550. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  209. BROOKS KM, George JM, Pau AK, Rupert A, et al
    Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir with Once-Weekly Isoniazid and Rifapentine.
    Clin Infect Dis. 2018 Feb 3. pii: 4836314. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  210. LACOURSE SM, Cranmer LM, Njuguna IN, Gatimu J, et al
    Urine TB lipoarabinomannan (LAM) predicts mortality in hospitalized HIV-infected children.
    Clin Infect Dis. 2018 Jan 6. pii: 4792803. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  211. BRUST JCM, Shah NS, Mlisana K, Moodley P, et al
    Improved survival and cure rates with concurrent treatment for MDR-TB/HIV co-infection in South Africa.
    Clin Infect Dis. 2017 Dec 26. pii: 4774985. doi: 10.1093/cid/cix1125.
    PubMed     Abstract available


    September 2017
  212. THAO LTP, Heemskerk AD, Geskus RB, Mai NTH, et al
    Prognostic models for 9 month mortality in tuberculous meningitis.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Abstract available


  213. NEMES E, Hesseling AC, Tameris M, Mauff K, et al
    Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: